Curaleaf (OTCMKTS:CURLF) Upgraded by Cormark to Moderate Buy Rating

Key Points

• Curaleaf has been upgraded by Cormark from a "hold" rating to a "moderate buy" rating, signaling increased optimism from analysts.
• Shares of Curaleaf saw a significant 14.0% increase on the day following the upgrade, opening at $2.04.
• Despite a reported loss of ($0.06) EPS for the last quarter, Curaleaf exceeded analysts' expectations and is projected to post -0.25 EPS for the current year.

Cormark upgraded shares of Curaleaf (OTCMKTS:CURLF - Free Report) from a hold rating to a moderate buy rating in a report released on Friday morning,Zacks.com reports.

Curaleaf Trading Up 9.9%

OTCMKTS:CURLF traded up $0.27 on Friday, reaching $2.99. The stock had a trading volume of 1,648,186 shares, compared to its average volume of 746,791. The company has a market cap of $2.00 billion, a price-to-earnings ratio of -9.34 and a beta of 0.69. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.47 and a quick ratio of 0.70. The firm's fifty day moving average is $1.15 and its two-hundred day moving average is $1.07. Curaleaf has a 12-month low of $0.68 and a 12-month high of $3.58.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.61%. Equities analysts expect that Curaleaf will post -0.25 EPS for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.